Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018)
Celldex Therapeutics (CLDX) posted quarterly Amortization - Intangibles of $224000.0 for Q1 2018, little changed year-over-year from $224000.0 in Q1 2017, and little changed quarter-over-quarter from $224000.0 in Q4 2017.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018) Analysis & Trends
Celldex Therapeutics' Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $224000.0 for Q1 2018.
- In Q1 2018, Amortization - Intangibles changed 0.0% year-over-year to $224000.0; the TTM figure through Dec 2018 stood at $224000.0 (down 75.0% YoY), while the FY2018 annual figure was $224000.0, down 75.0% from the prior year.
- Amortization - Intangibles for Q1 2018 stood at $224000.0, roughly flat from $224000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $254000.0 in Q2 2014, with the low at $224000.0 in Q1 2017.
- The 5-year median for Amortization - Intangibles is $253000.0 (2014), against an average of $243882.4.
- The sharpest annual moves came in 2014 and 2017: Amortization - Intangibles changed 0.0% in 2014, then decreased 11.81% in 2017.
- Celldex Therapeutics' Amortization - Intangibles stood at $253000.0 in 2014, then changed by 0.0% to $253000.0 in 2015, then retreated by 6.32% to $237000.0 in 2016, then dropped by 5.49% to $224000.0 in 2017, then changed by 0.0% to $224000.0 in 2018.
- Business Quant data shows CLDX's Amortization - Intangibles at $224000.0 in Q1 2018, $224000.0 in Q4 2017, and $224000.0 in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.07 Bn | 3.07 Bn | -2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 224,000.00 |
| Dec 31, 2017 | 224,000.00 |
| Sep 30, 2017 | 224,000.00 |
| Jun 30, 2017 | 224,000.00 |
| Mar 31, 2017 | 224,000.00 |
| Dec 31, 2016 | 237,000.00 |
| Sep 30, 2016 | 254,000.00 |
| Jun 30, 2016 | 254,000.00 |
| Mar 31, 2016 | 253,000.00 |
| Dec 31, 2015 | 253,000.00 |
| Sep 30, 2015 | 254,000.00 |
| Jun 30, 2015 | 254,000.00 |
| Mar 31, 2015 | 253,000.00 |
| Dec 31, 2014 | 253,000.00 |
| Sep 30, 2014 | 254,000.00 |
| Jun 30, 2014 | 254,000.00 |
| Mar 31, 2014 | 253,000.00 |
| Dec 31, 2013 | 253,000.00 |
| Sep 30, 2013 | 254,000.00 |
| Jun 30, 2013 | 254,000.00 |